# FDA Inspection 1194407 - Penn Fertility Care - Lancaster General Health - December 14, 2022

Source: https://www.keypedia.com/records/fda_inspections/penn-fertility-care-lancaster-general-health/d03fcd4a-e1d5-471e-a872-984c7517f556
Source feed: FDA_Inspections

> FDA Inspection 1194407 for Penn Fertility Care - Lancaster General Health on December 14, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1194407
- Company Name: Penn Fertility Care - Lancaster General Health
- Inspection Date: 2022-12-14
- Classification: No Action Indicated (NAI)
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1194407 - 2022-12-14](https://www.keypedia.com/records/fda_inspections/penn-fertility-care-lancaster-general-health/2799b8f0-a984-4628-8074-3983cb3063cc)
- [FDA Inspection 1194407 - 2022-12-14](https://www.keypedia.com/records/fda_inspections/penn-fertility-care-lancaster-general-health/a34bab52-f396-4851-96df-f4fb8b765d32)

Company: https://www.keypedia.com/companies/penn-fertility-care-lancaster-general-health/a328f71a-d9ae-4724-a81f-477777a9c095

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
